ask="7.40"
ask_size="100"
average_daily_volume="35557"
bid="6.10"
bid_size="100"
book_value="1.99"
change="-0.04"
change_from_200_day_moving_average="-0.99"
change_from_50_day_moving_average="-0.05"
change_from_52_week_high="-4.32"
change_From_52_week_low="0.59"
change_in_percent="-0.64%"
close="6.19"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.87"
ebitda="-10.01M"
eps_estimate_current_year="-0.62"
eps_estimate_next_quarter="-0.13"
eps_estimate_next_year="-1.01"
ex_dividend_date="N/A"
float_shares="8645000"
high="6.38"
high_52_weeks="10.51"
last_trade_date="1/9/2017"
last_trade_price="6.19"
last_trade_size="102"
last_trade_time="4:00pm"
low="6.12"
low_52_weeks="5.60"
market_capitalization="82.10M"
moving_average_200_day="7.18"
moving_average_50_day="6.24"
name="Oramed Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="18.00"
open="6.20"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-13.83%"
percent_change_from_50_day_moving_average="-0.78%"
percent_change_from_52_week_high="-41.10%"
percent_change_from_52_week_low="+10.54%"
previous_close="6.23"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.14"
price_per_sales="128.92"
revenue="640999.00"
shares_outstanding="13264000"
short_ratio="6.22"
stock_exchange="NCM"
symbol="ORMP"
volume="30394"
weeks_range_52="5.60 - 10.51"
